Manoj Sharma, MD
Interventional Cardiology · Saginaw, MINPI 1033105242
Payments from drug & device makers
Across 284 payments — averaging $36.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$5K
- Medtronic$1K
- Abiomed$760
- Boston Scientific$666
- Novartis$414
- Abbott$313
- plus $2K from 33 others
What the payments were for
- Travel & lodging$3,27031%
- Food & beverage$7,17969%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 66 | $5,023 |
| Medtronic(2 entities) | 15 | $1,006 |
| Abiomed | 20 | $760 |
| Boston Scientific | 15 | $666 |
| Novartis | 32 | $414 |
| Abbott | 19 | $313 |
| Shockwave Medical, Inc | 11 | $255 |
| Johnson & Johnson | 13 | $218 |
| E.r. Squibb & Sons, L.L.C. | 12 | $198 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 11 | $180 |
| Pfizer | 10 | $175 |
| Recor Medical Inc | 3 | $139 |
| Boehringer Ingelheim | 6 | $115 |
| Philips North America LLC | 2 | $110 |
| Sanofi-aventis U.S. LLC | 6 | $106 |
| Kestra Medical Technology Services, Inc. | 4 | $92 |
| Teleflex LLC | 5 | $84 |
| Lundbeck LLC | 4 | $74 |
| Amgen | 4 | $70 |
| Cordis US CORP. | 2 | $39 |
| Angiodynamics, Inc. | 1 | $39 |
| Cardiva Medical, Inc. | 2 | $38 |
| Cardiovascular Systems Inc. | 2 | $37 |
| Arbor Pharmaceuticals, Inc. | 2 | $31 |
| AstraZeneca | 2 | $30 |
| Atricure, Inc. | 1 | $25 |
| Kowa Pharmaceuticals America, Inc. | 2 | $25 |
| Siemens Medical Solutions USA, Inc. | 1 | $24 |
| Bayer | 1 | $21 |
| Actelion Pharmaceuticals US, Inc. | 1 | $19 |
| Biotronik Inc. | 1 | $18 |
| Biosense Webster, Inc. | 1 | $18 |
| Merck | 1 | $17 |
| Scpharmaceuticals Inc. | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $16 |
| ZOLL Circulation Inc | 1 | $15 |
| Cardinal Health 200 LLC | 1 | $14 |
| Terumo Medical Corporation | 1 | $13 |
| Irhythm Technologies, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Edwards SAPIEN 3 Transcatheter Heart Valve$1,307
- COREVALVE EVOLUT R$526
- PASCAL$524
- SAPIEN 3 Ultra RESILIA$327
- Impella$225
- ROTABLATOR$142
- CROSSBOSS$140
- CoreValve Evolut$124
How this compares
$10,463 in reported general payments places this provider in the 50th percentile of 187 interventional cardiology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 664 | $817,740 |
| EntrestoSacubitril/Valsartan | 140 | $149,259 |
| XareltoRivaroxaban | 83 | $123,418 |
| JardianceEmpagliflozin | 92 | $116,220 |
| MultaqDronedarone Hcl | 51 | $91,106 |
| Repatha SureclickEvolocumab | 83 | $68,867 |
| BrilintaTicagrelor | 58 | $44,114 |
| Praluent PenAlirocumab | 14 | $12,974 |
| Metoprolol Succinate | 674 | $12,920 |
| Repatha SyringeEvolocumab | 12 | $12,874 |
| Propafenone Hcl ErPropafenone Hcl | 30 | $11,193 |
| Rosuvastatin Calcium | 460 | $10,382 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 537 | $10,095 |
| Ranolazine ErRanolazine | 64 | $9,190 |
| Diltiazem 24hr Er (La)Diltiazem Hcl | 46 | $7,338 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $175 | $817,740664 claims |
| NovartisEntresto | $414 | $149,259140 claims |
| Johnson & JohnsonXarelto | $218 | $123,41883 claims |
| Boehringer IngelheimJardiance | $115 | $116,22092 claims |
| Sanofi-aventis U.S. LLCMultaq | $106 | $91,10651 claims |
| AstraZenecaBrilinta | $30 | $44,11458 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 187 interventional cardiology providers in Michigan.
Other interventional cardiology in Saginaw
- Safwan KassasSaginaw$552K
- Daniel LeeSaginaw$315K
- John CollinsSaginaw$245K
- Chalapathirao GudipatiSaginaw$79K
- Bashar Al JayyousiSaginaw$60K
- Umesh BadamiSaginaw$44K
- Amer KadriSaginaw$42K
- Amir KakiDetroit$2.3M
- William MerhiGrand Rapids$2M
- Shukri DavidSouthfield$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.